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transmembrane receptors, communicate signals that
affect cell shape and motility.5
ECM properties
General principles of ECM organization are well
known. Organized ﬁbrous polymers, including colla-
gens, elastins, and resilins, are embedded within an
amorphous mixture of nonﬁbrous components as the
fundamental theme. The need for inextensibility cou-
pled with great strength mandates the presence of ﬁ-
brous macromolecules, primarily those that aggregate
into near crystalline arrays such as the collagens.6 Tissue
resilience becomes predominant when elastic ﬁbers
such as elastin and resilin are strategically located in
tissues. The amorphous substances in the ECM are pre-
dominantly proteoglycans, which can impart turgor.7,8
Adhesive glycoproteins, such as laminin, ﬁbronectin,
and entactin (nidogen), are enriched in basement mem-
branes9–13  and are speciﬁcally recognized by discrete
integrins.
The relative proportion of ﬁbrous and nonﬁbrous
components partially dictate the overall physical prop-
erties of a particular ECM, as does the diameter and
weave of the ﬁbers and the organizational arrangement
of nonﬁbrous substances. We recognize ECM proteins
as large, multifunctional molecules. They contain many
domains, often repeated and occurring in tandem
with each other. The domains yield various three-
dimensional structures, often imparting several func-
tions to one macromolecule.2  Such functions include
recognition by integrins and other cell receptors, ability
to form coiled coils, predisposition to oligomerize,
speciﬁc recognition by metalloproteinases,14,15 and abil-
ity to form distinct intramatrix interactions.
I dedicate this lecture to the memory of Professor Katsuyuki
Fujii, MD. Early in his career Professor Fujii studied as a
postdoctoral research fellow in my laboratory. He was one of
my most outstanding students and has been acclaimed as a
leader by the international orthopedic community.
Extracellular matrix origin
The extracellular matrix (ECM) provides the scaffold-
ing, support, and strength to tissues and organs. The
ECM appeared during evolution with the advent of
multicellular invertebrate animals.1 The contemporary
animal species that represent those early invertebrates
contain the same macromolecular components found
in all ECM, namely collagens, proteoglycans, and
glycoproteins. New matrix domains appeared in multi-
cellular animals that had not been present in primordial
single-cell organisms, and the new domains then be-
came conserved in the multicellular organisms.2 More-
over, ancestral protein domains became genetically
rearranged in various matrix proteins, yielding new
molecules, including some whose functions remain to be
discovered.3
It is commonly believed that the ECM provides a
framework for cell adhesion and tissue development.
We now know that cells have well-developed communi-
cation pathways between cell surfaces and the ECM.4
The view from the cell surface outward to the ECM has
two perspectives: one toward the basement membrane
and the other toward the interstitial matrix. Cells adher-
ent to a basement membrane are necessarily polarized,
containing basal and apical regions; and they show a
precise orientation within speciﬁc tissues and organs.
These cells rely primarily on integrins for recognition of
basement membrane components; the integrins, as
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Collagen family
The most abundant ECM components tend to be large
and have complex, unique structures. For example,
collagenous proteins are deﬁned by their presence of
gly-X-Y repetitive sequences that give rise to a
characteristic triple-helix conformation. That confor-
mation might occur just once in a protein, may be
present many times in tandem with noncollagen do-
mains, or may comprise the entire protein. The family
of collagenous proteins now includes representatives of
each of these types. Collagenous family members are
highly diverse,16  including the classical ﬁber-forming
collagens, amorphous collagens such as the ones that
form basement membranes, specialized collagens that
organize into compact unique structures, and trans-
membrane collagens.17
Because the collagens are often crucial for tissue
structure and function, defects in their normal expres-
sion may produce lethal and nonlethal phenotypes.16,18
Mutations of collagenous proteins are responsible for
many clinical syndromes, affecting skeletal and
nonskeletal tissues. The syndromes range from lethal to
nonlethal, the latter ranging from mild clinical entities
to debilitating disorders such as diverse forms of
osteognesis imperfecta. Analogous mutations of colla-
genous proteins are seen in domestic and laboratory
animals, helping to establish the role of a speciﬁc colla-
gen in physiologic homeostasis.
Biosynthesis of collagens necessarily must be
complex to accommodate formation of a unique
triple-helix conformation as well as including post-
translational modiﬁcations such as proline and lysine
hydroxylation. Proline hydroxylation yields primarily 4-
hydroxyproline, which is responsible for stabilizing the
molecular triple helix. Lysine hydroxylation, in con-
trast, is needed to stabilize the intermolecular crosslinks
that develop between collagen molecules within colla-
gen polymers.19  Such crosslinks help retain collagen
polymer organization, enabling tensile forces to be
transmitted without causing disruption of tissues and
organs.
Collagenous proteins are synthesized as precursor
forms, the procollagens, which are larger than the corre-
sponding mature collagen molecules.20,21 Proper conver-
sion of procollagen to collagen is essential, as mutations
in that conversion process may also lead to defective
individuals who clinically resemble those with a speciﬁc
collagen mutation.
Many central details of collagen biosynthesis are
known.22 A nascent collagenous chain is synthesized, as
a procollagen precursor, on ribsomes bound to the
cytoplasmic surface of the endoplasmic reticulum (ER).
The growing nascent chain enters the cisternal com-
partment of the ER and, upon chain completion, is
released therein. Posttranslational hydroxylation and
glycosylation occurs at this stage. Then, three nascent
chains must recognize each other at their carboxyl ter-
mini to form the proper molecular composition (there
are many genetically different chains), and the chains
must align in proper register prior to zipping up into a
triple helix conformation. The helical procollagen is
transported from the ER to the Golgi region and is then
secreted from the cell where the procollagen amino-
and carboxyl-terminal domains are cleaved by speciﬁc
proteases. The residual collagen molecule undergoes
oxidation of speciﬁc lysines and hydroxylysines into
aldehydes, catalyzed by lysyl oxidase, setting the
scene for intermolecular crosslinking. The modiﬁed
collagen self-assembles into ﬁbrils or, in the case of
nonﬁbrillar collagens, into random types of polymer.
These macromolecular structures progressively develop
crosslinks, gaining strength and imparting tensile prop-
erties to tissues and organs.19
Importantly, there are a large number of noncollagen
mutations that affect skeletal patterning and differen-
tiation, resulting in a great variety of body shape disor-
ders that alter the axial skeleton, the facial skeleton, and
the limbs.16,18  The mutated genes include those for
growth factors and their receptors, transcription factors,
homeoboxes, structural proteins such as cartilage oligo-
meric matrix protein (COMP), proteoglycans, hormone
receptors, and vitamin receptors. Given such a wide
variety of noncollagen genes it is not surprising that
noncollagen mutations are more numerous than colla-
gen mutations. Certain transciptional factors play criti-
cal roles in early skeletal development.23 They include
Sox9, L-Sox5, Sox6, and Runx2, which are essential for
cartilage formation; Sox9, Runx2, and Osterix are cru-
cial for bone development.
Proteoglycans
Mature articular cartilage owes its resilience to the
presence of aggrecan, a prototypical proteoglycan.
Aggrecan’s role was dramatically illustrated by Lewis
Thomas’ accidental results, when he caused erect rabbit
ears to collapse by intravenously injecting the protease
papain. Thomas astutely recognized that his dramatic
result would provide insight into proteoglycan proper-
ties; he demonstrated that the affected rabbit ear carti-
lage lost its characteristic metachromatic staining, a
hallmark of tissue proteoglycans. Amazingly, the rab-
bits recovered within a week, their ears regaining erect
stature with restoration of the cartilage metachromatic
staining. These observations were made prior to the
molecular characterization of aggrecan but are sufﬁ-
cient to illustrate its essential role in creating cartilage
turgor.328 M.L. Tanzer: Extracellular matrix
Aggrecan’s critical role in skeletal development is
illustrated by the chicken mutation nanomelia; the
mutant animals fail to survive The affected animals are
dwarfs with insigniﬁcant amounts of cartilage; conse-
quently, the bones fail to develop because they rely
on a preformed cartilage template for development.
Genetic analysis shows that a truncated aggrecan core
protein is present in the mutant animals; the protein is
about two-thirds normal length due to a premature stop
codon. The missing portion of the core protein appears
essential for proper routing of the core protein from the
ER cisternal compartment into the Golgi region, ordi-
narily followed by secretion from the chondrocyte.
Nanomelic core protein remains in the chondrocyte ER
lumen without moving forward, and so nanomelic carti-
lage ECM is devoid of aggrecan.
Proteoglycans7,8  are implicated in other biological
processes, serving as repositories for growth factors,
assisting in modulating developmental processes,
and playing recognition roles at cell surfaces. Molecular
cloning has revealed families of proteoglycans; for
example, aggrecan, brevican, versican, and neurocan
are members of the lectican family, binding hyaluronan
at their amino termini, whereas their C-termini have
a selectin domain. The lecticans are decorated pre-
dominantly with chondroitin sulfate glycosaminoglycan
(GAG) chains, with lesser numbers of keratan
sulfate chains. Versican has been implicated in stimulat-
ing proliferation of ﬁbroblasts and chondrocytes,
apparently via its epidermal growth factor (EGF)-like
motifs.
Numerous GAG-binding proteins have been de-
scribed in the literature. The interaction between
GAGs and proteins can have profound physiological
effects on hemostasis, lipid transport and absorption,
cell growth and migration, and development. Binding to
GAGs can result in immobilization of proteins at their
sites of production and in the matrix (potentially for
future mobilization), regulation of enzyme activity,
binding of ligands to their receptors, and protection of
proteins against degradation. In some cases, the interac-
tion has been shown to depend on a minor but highly
speciﬁc sequence of modiﬁed sugars in the GAG chain.
Most of the GAG-binding proteins that have been
described interact with heparin/heparan sulfate or
hyaluronic acid; relatively few are known to interact,
with comparable avidity and afﬁnity, with chondroitin
sulfate or keratan sulfate.
One proteoglycan family has a protein core com-
posed of leucine-rich repeats; members are decorin,
biglycan, ﬁbromodulin, and keratocan. They help or-
ganize collagen ﬁbrillar networks and are decorated
with chondroitin/dermatan sulfate or keratan sulfate.
Decorin has recently been shown to participate in cellu-
lar signal transduction via the EGF receptor with down-
stream signaling through the mitogen-activated protein
kinase (MAPK) pathway.
Proteoglycan GAG chains play vital roles in tissues
by interacting with speciﬁc domains of other proteins.
This phenomenon has been best characterized for the
heparan sulfate proteoglycans, in particular the anti-
coagulant heparin, which speciﬁcally binds to circulat-
ing antithrombin, thereby inhibiting blood clotting.
Heparin is used clinically to prevent blood clotting rap-
idly in patients who have a life-threatening thrombosis.
This useful property of heparin has been pinpointed to
a speciﬁc structure in heparin GAG chains, a unique
pentasaccharide that binds to antithrombin with high
afﬁnity.
Cells also elaborate a diverse group of membrane
proteoglycans that typically have type I orientations
and either single membrane-spanning domains or a GPI
anchor. Membrane proteoglycans tend to contain
mostly HS (the glypicans), but many are hybrid struc-
tures containing both HS and CS (the syndecans and
betaglycan). A few membrane proteoglycans contain
exclusively CS (CD44 and NG2).
These cell membrane-associated proteoglycans bind
to growth factors, forming ternary structures containing
the proteoglycan plus the growth factor and its receptor.
Such complexes modulate the signaling response of
cells once they bind a growth factor. Syndecans are
known to create such complexes with ﬁbroblast growth
factor, hepatocyte growth factor, platelet-derived
growth factor, heparin-binding epidermal growth fac-
tor, and vascular endothelial growth factor. Down-
stream cellular activites such as adhesion, migration,
proliferation, and differentiation are altered, demon-
strating the importance of such ternary cell surface
complexes.
Basement membranes
Virtually all organs and tissues in the adult animal have
an organized architecture containing cells adherent to
an underlying basement membrane. Ordinarily, the ad-
herent cells do not move; and with few exceptions, the
basement membrane is an impermeable barrier to cell
migration. Leukocytes breach that barrier when they
are recruited from the capillary for body defense, for
example, against bacteria present in tissues. During
pregnancy, the trophoblast invades the subendothelial
basement membrane of the uterus, but this becomes
reversible with expulsion of the placenta after birth.
Metastatic cancer cells enter the circulation by breach-
ing the basement membrane at the primary cancer site
and breach it again upon entering the parenchyma of a
distant tissue. This behavior is reminiscent of migrating
cells during embryonic development, a stage when base-329 M.L. Tanzer: Extracellular matrix
ment membranes are not impermeable to cell penetra-
tion, in contrast to adult tissues.
Basement membranes are predominantly composed
of: (1) type IV collagen, a nonﬁbrous polymer; (2)
laminin, an adhesive glycoprotein; (3) ﬁbronectin, an-
other adhesive glycoprotein; (4) entactin (nidogen); (5)
and perlecan, a proteoglycan.9–13,24,25 Small amounts of
other proteoglycans and glycoproteins are also found in
basement membranes. Ultrastructural and microscopic
observations do not reveal obvious architectural differ-
ences, comparing basement membranes of various or-
gans and tissues; however, immunostaining does reﬂect
the genetic heterogeneity of both the collagen and
laminin components. There are ﬁve known genes
encoding for type IV collagen, providing molecular
diversity in collagen chain composition. Laminin has a
cruciform structure organized about three genetically
separate chains, and each chain has isogenic forms; 12
different laminin molecules are generated from multi-
ple genetically distinct chains. Both type IV collagen
and laminin molecular isoforms are synthesized by cells
in a tissue-speciﬁc manner, as reﬂected by distinct
immunstaining patterns.
Reconstitution studies show that type IV collagen
polymerizes to form a scaffold that is recognized by
nidogen, laminin, and perlecan. The latter molecules
bind to the scaffold, creating an interlocking network
that becomes tough and insoluble. It serves as a barrier
to large solutes and is impenetrable to most cells in
adult tissues, save for the exceptions noted above.
Laminins
The prototypical laminin molecule was discovered in
the mouse EHS sarcoma more than 20 years ago and
was quickly shown to be abundant in basement
memranes. The cruciform laminin molecule contains an
alpha, beta, and gamma chain; to date there are ﬁve
alpha chains, three beta chains, and three gamma
chains, each encoded by individual genes. Twelve dis-
tinct laminin molecular isoforms have been character-
ized. They share certain domains, such as binding sites
for nidogen and for integrins, which are transmembrane
receptors that enable cells to recognize and respond to
the ECM.
Individual laminins9,10,12  modulate certain cell func-
tions. These functions include differentiation of epithe-
lial cells, neurite outgrowth, anchoring of epidermal
basal cells, and anchoring of leukocytes that are exiting
from the microvasculature.
Laminin isoforms are produced by a wide variety of
cells, primarily in a tissue-speciﬁc manner, as reﬂected
by immunostaining patterns and conﬁrmed by bio-
chemical analyses of cell cultures that produce laminin.
Thus, epithelial cells, muscle (smooth, skeletal, cardiac)
cells, nerve cells, endothelial cells, marrow cells, and
neuroretinal cells all produce laminin. The secreted
laminin becomes deposited with nidogen, perlecan, and
type IV collagen in basement membranes.
Fibronectins
Fibronectins11,13,24 are multifunctional glycoproteins that
play a central role in cell adhesion. They are
heterodimeric molecules that contain three types of re-
peating domain, termed I, II, and III. More than half of
the molecule consists of type III repeats. Fibronectin
has binding domains that recognize ﬁbrin, heparin, col-
lagen, integrins, and other cell surface moieties.
Fibronectin molecular isoforms arise via alternative
splicing of a single gene. Protein products are disulﬁde-
linked heterodimers of 235–270kDa that are decorated
with  N- and O-linked carbohydrates. Fibronectin is
abundant in the blood and in most tissues, where it
assembles into ﬁbrils that enhance cell adhesion.
Integrins
A family of heterodimeric receptor molecules,
integrins4,5 enable cells to adhere to the ECM. Integrins
provide mechanical continuity between the interior and
exterior of the cell. Integrins contain an alpha subunit
and a beta subunit joined by disulﬁde bonds; currently
there are 18 alpha and 3 beta subunits, which are organ-
ized into 24 distinct integrins. Ligand recognition is
related to integrin subunit composition, but there is
considerable ligand overlap between many integrins.
Collagens, laminins, ﬁbronectins, and leukocyte-speciﬁc
surface moieties are ligands.
Interior linkage of integrins to the actin cytoskeleton
is mediated via a repertoire of linker proteins including
talin, α-actinin, vinculin, and paxillin. Integrin engage-
ment by an ECM ligand triggers a signaling cascade that
affects cell survival, cell motility, cell proliferation, and
gene transcription. Cell migration necessarily requires
that integrins at the leading edge of a motile cell be
transiently attached to the ECM, whereas those at the
trailing edge release their contacts as the cell moves.
This attachment–detachment cycle has been clearly
demonstrated in cell cultures in which intracellular actin
has been vitally stained with green ﬂuorescent protein
(GFP) molecules. Similarly, single cell coalescence into
multicellular cords and ribbons has been tracked in cell
culture, demonstrating another level of complexity, that
of cell–cell recognition.
Integrin molecular motion has been deduced by X-
ray diffraction analyses of integrin-bound ligands. Con-330 M.L. Tanzer: Extracellular matrix
formational changes in the integrin structure occur in
cyclic fashion, enabling binding and release of ligand,
thereby accounting for the attachment–detachment
phases of cell motility. Thus, integrin molecular move-
ment is transformed into cellular motion. This concep-
tual framework provides insight into the phenomenon
of leukocyte diapedesis, that is, the departure of
leukocytes from the microvasculature into tissue paren-
chyma. A leukocyte that has attached to the basement
membrane underlying the vascular endothelium is using
its integrins for primary contact with the ECM; the
leukocyte then elaborates matrix metalloproteases to
provide a small puncture for cell entry into the underly-
ing parenchyma. Directed leukocyte motion then oc-
curs via the attachment–detachment mechanism of its
surface integrins.
Similar considerations apply to cancer cell metastasis.
Here, the invading cells depart from the primary
cancer site, migrate to a vascular channel, puncture
the endothelial basement membrane, enter the circula-
tion, and then depart from the vascular channel in a
manner corresponding to the leukocyte pathway. It is
in this way that distant metastases develop in various
organs.
Matrix metalloproteinases
Leukocyte diapedesis and cancer cell metastasis require
these migrating cells to penetrate basement mem-
branes. The cells can do so because they are armed with
a repertoire of proteolytic enzymes, the matrix
metalloproteinases (MMPs).14,15  Currently, more than
20 mammalian MMPs have been isolated and character-
ized. Although each enzyme has unique speciﬁcity, in
combination the group can degrade all ECM proteins.
Most of the MMPs are secreted and released as inac-
tive proenzymes that have a catalytic domain containing
a zinc-bound active site consensus sequence. Some
MMPs have additional molecular features that enhance
their biological activities, such as adhesion to cell sur-
faces via their tandem ﬁbronectin repeat sequences.
Some members of the MMP family have transmem-
brane domains, ensuring their sustained proximity to
the cell surface.
Metalloproteinases are produced by a wide variety
of cells, normal and abnormal. Ordinarily, cells at rest
exhibit low levels of MMPs, but when cytokines and
growth factors stimulate cells during infection or tissue
remodeling MMP levels rapidly increase. MMP expres-
sion is controlled in multiple ways, including transcrip-
tion, proteolytic activation, tissue localization, and
inhibitor binding. Activation ordinarily occurs via other
proteases removing the prodomain, but autocatalytic
activation may occur as well.
Secreted MMPs seem to localize transiently at the cell
surface via interactions with cell surface adhesion
receptors and proteoglycans. Localization may be
needed for proper ECM degradation and may also
protect MMPs from inhibitors, especially the tissue
inhibitors of metalloproteinases (TIMPs). MMPs seem
responsible for augmenting the release of bound growth
factors from the ECM and may activate latent growth
factors such as transforming growth factor β  and  α
(TGFβ, TGFα), insulin-like growth factor (IGF), and
heparin-binding epidermal growth factor (HB-EGF).
Finally, MMPs are known to cleave cell surface
receptors that recognize growth factors, cytokines, and
chemokines. In sum, MMPs are potent regulators of
normal and abnormal cell physiology.
Future prospects
The explosion in biological information during the past
25 years has illustrated the great complexity of nature
and has provided a rich tapestry that is just unfolding for
the scientiﬁc community. Unlike an earlier era when
great advances were made in deciphering fundamental
laws of physics, biology seems limited by its very nature
to rely on generalizations that often contain exceptions.
Even such a key point as the “central dogma” of infor-
mation ﬂow from nucleic acids to proteins allows that
RNA or DNA may be the repository of information,
depending on a particular species and its genome. For
example, some viral genomes are encoded in RNA, not
DNA.
The great success in understanding the building
blocks of cells and the ECM emerged when a
reductionist strategy was used to identify, isolate, and
characterize molecular components. The relation of
such components to each other and to the genome is
now under investigation using the strategy of systems
biology.26–29 Here, the intent is to decipher the relations
between components of pathways and between
pathways. Thus, genomics, proteomics, glycomics,
metabolomics, and signalomics are all legitimate
“omics” under intense study; basically, such systems
analyses will illustrate how molecular components in-
teract to create dynamic functional activities. Recent
examples are yeast systems analysis and systems analy-
sis of early embryonic development. Some insight into
the pathogeneis of osteoarthritis has been made by
using similar systems analysis methods; detailed rela-
tionships were illustrated, comparing anabolic and cata-
bolic pathways in normal and osteoarthritic articular
cartilage.30
Potentially, such a systems biology strategy can help
decipher the pathogenesis of complex diseases and pro-
vide insight into tailoring medications that interfere331 M.L. Tanzer: Extracellular matrix
with critical pathways, thereby stopping disease pro-
gression. Ideally, early interception of disease states
before signiﬁcant irreversible damage occurs may be-
come possible by developing tools that identify indi-
viduals at risk for speciﬁc diseases. Initially, genomic
analyses can be implemeted; later, as other tools such as
proteomics and glycomics come on stream, they will
provide important ancillary information. In this way,
individual proﬁles can be made at one’s request, similar
to contemporary genetic testing to detect hereditary
diseases. Progressive developments in technology will
make this idea into reality in the near future, opening a
new dimension in disease prevention.
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